B3 Cuts Skin Cancer Risk 54%

In what could be a game-changer for skin cancer prevention, new research reveals that a daily dose of vitamin B3 may significantly reduce the risk of developing these common cancers. This isn’t just another health fad – we’re talking about a simple, over-the-counter supplement that cuts skin cancer risk by an impressive 14% for the general population and an astonishing 54% for those who’ve previously been diagnosed.

The Science Behind Vitamin B3 and Skin Cancer Prevention

The magic ingredient in question is niacinamide, a form of vitamin B3 that’s found naturally in foods and available as a dietary supplement. While you might associate B3 with energy metabolism, researchers have discovered it plays a crucial role in protecting our skin from cancer development.

Niacinamide works by supporting cellular energy production, DNA repair mechanisms, and maintaining healthy skin function. Think of it as giving your skin cells a toolkit to fight off the damage that leads to cancer. Unlike its cousin niacin (another form of vitamin B3), niacinamide doesn’t cause the uncomfortable flushing sensation that can occur with niacin supplementation.

The Groundbreaking ONTRAC Trial

The foundation for these exciting findings comes from the 2015 Australian ONTRAC (Oral Nicotinamide To Reduce Actinic Cancer) trial, a landmark phase III clinical study. This robust research, published in the New England Journal of Medicine by Chen et al., examined high-risk patients and found a 23% reduction in new non-melanoma skin cancers among those taking niacinamide regularly.

For context, that’s the gold standard of medical evidence – a large, randomized, controlled trial that meets the highest scientific standards.

What the Latest Research Reveals

Building on those initial findings, researchers from Vanderbilt University Medical Center conducted an even larger real-world analysis, examining health records of 33,822 US veterans. This study, published in 2025, confirmed and expanded upon the earlier research with some remarkable insights:

For the general population taking niacinamide: 14% reduced risk of skin cancer
For those with previous skin cancer diagnoses: A massive 54% reduced risk
Effective against both major types of non-melanoma skin cancer: basal cell carcinoma and cutaneous squamous cell carcinoma
Most pronounced effects seen in squamous cell cancers

Understanding the Numbers

Let’s put those percentages in perspective. With approximately 5.4 million basal and squamous cell skin cancers diagnosed each year in the US alone, even a 14% reduction represents hundreds of thousands of potential cancer cases prevented. For the 54% figure, we’re talking about potentially sparing over half of previously diagnosed patients from recurrence.

Dr. Lee Wheless of Vanderbilt University Medical Center notes, “There are no guidelines for when to start treatment with nicotinamide for skin cancer prevention in the general population. These results would really shift our practice from starting it once patients have developed numerous skin cancers to starting it much earlier.”

What Types of Skin Cancer Does This Affect?

The research specifically targets the two most common forms of non-melanoma skin cancer:

Basal Cell Carcinoma (BCC): Accounting for about 80% of all skin cancer cases, BCC is the most common form, with an estimated 3.6 million cases diagnosed annually in the US
Cutaneous Squamous Cell Carcinoma (SCC): The second most common type, with between 186,000 and 700,000 cases diagnosed yearly in the US

These cancers, while rarely fatal, can be disfiguring and require surgical intervention. They’re also expensive to treat – the American Cancer Society estimates that skin cancer treatment costs billions of dollars annually in the US.

Practical Application: Dosage and Safety

The typical dosage used in studies involves 500 mg of niacinamide taken twice daily for at least 30 days. This is significantly higher than the recommended daily allowance of vitamin B3 (14-16 mg for adults) but is still considered safe for most people.

Unlike some other forms of vitamin B3, niacinamide doesn’t cause the flushing effect that some people experience with niacin supplements. It’s also inexpensive – typically costing less than a dollar per day.

Potential Side Effects

While generally well-tolerated, some people may experience:

Mild gastrointestinal upset
Headaches
Dizziness

People with liver disease, kidney problems, or those taking certain medications should consult with their healthcare provider before starting supplementation. Those with a history of stomach ulcers or gallbladder disease should also exercise caution.

Putting This Into Practice

So should you run to the drugstore and start popping vitamin B3 supplements? While the research is promising, dermatologists recommend a balanced approach:

Don’t abandon sun protection: Vitamin B3 is not a replacement for sunscreen, protective clothing, and avoiding peak sun hours
Consult your dermatologist: Especially if you have a history of skin cancer or are at high risk
Consider your overall health: Supplements work best as part of a comprehensive health approach

Who Should Consider This?

This intervention appears most beneficial for:

People with a history of skin cancer (where the 54% risk reduction is most significant)
Individuals with significant sun damage or multiple precancerous lesions
Those at high occupational or recreational sun exposure
People taking immunosuppressive medications

Beyond the Hype: A Balanced Perspective

While these findings are genuinely exciting, it’s important to note that vitamin B3 is not a miracle cure. It’s a preventive measure that works best alongside established skin cancer prevention strategies. The fact that it’s over-the-counter and inexpensive makes it accessible, but that doesn’t mean it should be taken lightly.

The research also raises interesting questions about the role of nutrition in cancer prevention. Niacinamide is found naturally in foods like meat, fish, eggs, and green vegetables – perhaps another reason to maintain a balanced diet.

This research represents a significant shift in how we approach skin cancer prevention. Rather than simply treating cancers after they develop, we’re moving toward a more proactive model that includes chemoprevention – using safe, effective substances to prevent cancer before it starts.

As Dr. Wheless points out, current medical practice often waits until patients have developed multiple skin cancers before implementing preventive measures. The vitamin B3 research suggests we could be much more proactive.

Conclusion

Daily vitamin B3 supplementation, specifically in the form of niacinamide, represents a promising, accessible, and affordable option for reducing skin cancer risk. With an average 14% risk reduction for the general population and a remarkable 54% reduction for those with previous diagnoses, it offers real hope in the fight against one of our most common cancers.

However, it’s crucial to remember that this is just one tool in the skin cancer prevention toolkit. Sun protection, regular skin checks, and professional dermatological care remain essential components of any comprehensive approach to skin health.

As always, consult with your healthcare provider before starting any new supplement regimen, especially if you have a history of skin cancer or other health conditions.